Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories cash
Cash and short-term investments held at the end of each period.
Bio-Rad Laboratories's cash was $1.62B at Jun 30, 2026. For fiscal 2025 it was $1.54B, down 7.5% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $1.79B in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | -7.5% |
| FY2024 | Dec 31, 2024 | $1.67B | +3.7% |
| FY2023 | Dec 31, 2023 | $1.61B | -10.3% |
| FY2022 | Dec 31, 2022 | $1.79B | +105.8% |
| FY2021 | Dec 31, 2021 | $870.24M | -12.6% |
| FY2020 | Dec 31, 2020 | $996.03M | -10.8% |
| FY2019 | Dec 31, 2019 | $1.12B | +31.8% |
| FY2018 | Dec 31, 2018 | $847.43M | +12.1% |
| FY2017 | Dec 31, 2017 | $756.14M | -10.0% |
| FY2016 | Dec 31, 2016 | $840.35M | +6.7% |
| FY2015 | Dec 31, 2015 | $787.54M | +12.9% |
| FY2014 | Dec 31, 2014 | $697.64M | +14.6% |
| FY2013 | Dec 31, 2013 | $608.92M | -33.9% |
| FY2012 | Dec 31, 2012 | $921.07M | +13.3% |
| FY2011 | Dec 31, 2011 | $813.12M | -20.7% |
| FY2010 | Dec 31, 2010 | $1.03B | +37.6% |
| FY2009 | Dec 31, 2009 | $744.81M | +264.2% |
| FY2008 | Dec 31, 2008 | $204.52M | +26.4% |
| FY2007 | Dec 31, 2007 | $161.76M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.62B | +17.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.56B | -5.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.54B | -7.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.42B | -12.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.37B | -15.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.66B | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.67B | +3.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.62B | -7.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.62B | -6.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.65B | -11.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.61B | -10.3% |
| Q3 FY2023 | Sep 30, 2023 | $1.76B | -4.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.72B | -12.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.85B | -10.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.79B | +105.8% |
| Q3 FY2022 | Sep 30, 2022 | $1.85B | +38.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.97B | +69.4% |
| Q1 FY2022 | Mar 31, 2022 | $2.07B | +103.3% |
| Q4 FY2021 | Dec 31, 2021 | $870.24M | -12.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.34B | +15.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.16B | +12.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.02B | -1.6% |
| Q4 FY2020 | Dec 31, 2020 | $996.03M | -10.8% |
| Q3 FY2020 | Sep 30, 2020 | $1.15B | +17.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.03B | +5.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.04B | +20.7% |
| Q4 FY2019 | Dec 31, 2019 | $1.12B | +31.8% |
| Q3 FY2019 | Sep 30, 2019 | $979.25M | +13.8% |
| Q2 FY2019 | Jun 30, 2019 | $981.86M | +20.0% |
| Q1 FY2019 | Mar 31, 2019 | $858.99M | +12.6% |
| Q4 FY2018 | Dec 31, 2018 | $847.43M | +12.1% |
| Q3 FY2018 | Sep 30, 2018 | $860.57M | +20.1% |
| Q2 FY2018 | Jun 30, 2018 | $818.25M | +14.8% |
| Q1 FY2018 | Mar 31, 2018 | $762.93M | +13.2% |
| Q4 FY2017 | Dec 31, 2017 | $756.14M | -10.0% |
| Q3 FY2017 | Sep 30, 2017 | $716.46M | -11.1% |
| Q2 FY2017 | Jun 30, 2017 | $712.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $674.08M | – |
| Q4 FY2016 | Dec 31, 2016 | $840.35M | – |
| Q3 FY2016 | Sep 30, 2016 | $806.12M | – |